Northern Trust’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
2022
Q3
$10K Hold
2022
Q2
$35K Hold
2022
Q1
$77K Sell
2021
Q4
$164K Hold
2021
Q3
$195K Sell
2021
Q2
$240K Sell
2021
Q1
$579K Buy
2020
Q4
$556K Sell
2020
Q3
$586K Buy
2020
Q2
$766K Sell
2020
Q1
$566K Buy
2019
Q4
$870K Sell
2019
Q3
$648K Buy
2019
Q2
$486K Buy